Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs iShares MSCI Australia ETF (EWA) Price & Performance

AbCellera Biologics IncTrade
iShares MSCI Australia ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs iShares MSCI Australia ETF — how do they compare? AbCellera Biologics Inc trades at $8.94 (market cap $2.99B), while iShares MSCI Australia ETF trades at $29.94. Which is the better fit depends on your goals.

ABCLEWA
Market Cap
$2.99B
Sector
HealthBroad Market / Factor
52-Week High
$9.76$30.41
52-Week Low
$2.78$24.95
Enterprise Value
$2.58B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

No Aura AI signal available yet.

iShares MSCI Australia ETF

EWA trades at $30.41, up 0.83% with a bullish technical bias from moving averages, though oscillators signal caution with RSI levels above 70 indicating potential overbought conditions. The stock shows strong momentum with ADX readings above 36, while support and resistance cluster near $30-$31. Recent corporate actions include a scheduled dividend of $0.40 per share for June 2026.

Outlook remains positive given technical strength, but elevated RSI warrants monitoring for pullbacks. Risks include macroeconomic sensitivity and sector competition. Investment appeal hinges on sustained earnings growth and dividend stability, with current levels offering limited upside near resistance.

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About iShares MSCI Australia ETF

EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.

Read more on EWA